Clinical Trial Update: Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the effects of prolonged-release fampridine on ambulatory function in patients with multiple sclerosis. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Prolonged-release Fampridine (fampridine extended-release)

Snippet

Sponsor: University of Zurich | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN